Latest filing published 26 Mar 2015 for Vitae Pharmaceuticals, Inc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Prospect Management Co II LLC: trading record in brief
Prospect Management Co II LLC discloses dealings in 2 companies, chiefly Vitae Pharmaceuticals, Inc and Vanda Pharmaceuticals Inc. We count 11 filings; the first trade dates from 18 April 2006 and the latest from 24 March 2015.
The open-market record is one-sided, with 1 purchase worth €4.2M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 26 March 2015, reports a transaction in Vitae Pharmaceuticals, Inc. The last insider purchase was made public on 1 October 2014, 4,422 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Prospect Management Co II LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 900,383 shares0Common StockSEC:0001104659-15-023109:0
- 20,357 shares0Common StockSEC:0001104659-15-023109:1
- 20,357 shares0Common StockSEC:0001104659-15-023109:2
- 1,530,269 sharesCommon StockSEC:0001209191-14-060754:3
- 76,949 sharesCommon StockSEC:0001209191-14-060754:4
- 102,301 sharesCommon StockSEC:0001209191-14-060754:2
- 261,977 sharesCommon StockSEC:0001209191-14-060754:0
- 261,977 sharesCommon StockSEC:0001209191-14-060754:1
- 671,807 shares@ US$8.00Common StockSEC:0001209191-14-060754:5Canonical exit: 28 Dec 2014 (T+90)
- 2,366,655 sharesCommon StockSEC:0001209191-06-024443:0
- 36,040 sharesCommon StockSEC:0001209191-06-024443:1
11 of 11 declarations
